Recombinant Human Putative uncharacterized protein CXorf69 (CXorf69)

Shipped with Ice Packs
In Stock

Description

Recombinant Production

Commercial sources produce partial recombinant CXorf69 proteins for research applications. Specifications from available products include:

ParameterDetails
Expression SystemUndisclosed (likely E. coli or mammalian systems)
Purity≥85% (SDS-PAGE verified)
TaggingVariable options (e.g., His, Myc)
FormulationLiquid or lyophilized powder
Storage-20°C/-80°C long-term; 4°C for working aliquots
ReconstitutionRequires Tris/PBS-based buffers with glycerol

Genetic and Clinical Associations

CXorf69 resides on the X chromosome, which houses genes linked to sex-linked disorders :

DisorderChromosomal Abnormality
Klinefelter’s SyndromeXXY configuration
Turner’s SyndromeMonosomy X (45,X)
Triple X Syndrome47,XXX

While no direct disease associations are established for CXorf69, its chromosomal location suggests potential roles in sex chromosome-related pathologies .

Research Applications

Recombinant CXorf69 is primarily used for:

  • Antibody Production: Generating custom antibodies for localization studies .

  • Functional Assays: Preliminary investigations into binding partners or enzymatic activities .

  • Disease Modeling: Exploring contributions to X-linked disorders .

Limitations and Future Directions

Current knowledge gaps include:

  • No resolved 3D structure or confirmed post-translational modifications.

  • Unclear subcellular localization or interaction networks.

  • Limited peer-reviewed studies validating its biochemical properties.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Our standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which may serve as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
SMIM10; CXorf69; Small integral membrane protein 10
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-83
Protein Length
full length protein
Species
Homo sapiens (Human)
Target Names
SMIM10
Target Protein Sequence
MEALGSGHYVGGSIRSMAAAALSGLAVRLSRPQGTRGSYGAFCKTLTRTLLTFFDLAWRL RKNFFYFYILASVILNVHLQVYI
Uniprot No.

Target Background

Database Links

HGNC: 41913

KEGG: hsa:644538

UniGene: Hs.42239

Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is known about the structural characteristics of CXorf69 protein?

The CXorf69 protein is a putative uncharacterized protein with a full length of 83 amino acids . As an uncharacterized protein, limited structural information is available, but researchers can employ several approaches to elucidate its structure:

Methodological Answer:

  • Begin with computational prediction methods (homology modeling, ab initio prediction) to generate hypothetical structural models

  • Validate predictions with circular dichroism (CD) spectroscopy to determine secondary structure elements

  • For definitive structure determination, purify sufficient quantities of the recombinant protein and attempt X-ray crystallography or NMR spectroscopy

  • Employ hydrogen-deuterium exchange mass spectrometry (HDX-MS) to gain insights into protein dynamics and solvent accessibility

When designing experiments to characterize structure, researchers should consider a multi-method approach that combines computational and experimental techniques to build a comprehensive structural profile.

How can I optimize expression of recombinant CXorf69 protein?

Methodological Answer:
When working with uncharacterized proteins like CXorf69, optimization of expression conditions is critical for obtaining sufficient quantities for functional and structural studies.

  • Expression System Selection: The protein has been successfully expressed in E. coli with a His-tag , but consider testing multiple expression systems:

Expression SystemAdvantagesLimitationsBest For
E. coliFast growth, high yield, low costLimited post-translational modificationsBasic structural studies
Insect cellsBetter folding, some PTMsHigher cost, longer production timeFunctional studies requiring some PTMs
Mammalian cellsNative-like folding and PTMsHighest cost, complex cultivationStudies requiring authentic protein activity
  • Optimization Parameters:

    • Test multiple fusion tags beyond His-tag (MBP, GST, SUMO)

    • Vary induction conditions (temperature, inducer concentration, duration)

    • Screen different cell lines and growth media formulations

    • Consider co-expression with chaperones if folding issues are encountered

  • Analytical Quality Assessment:

    • SDS-PAGE and western blotting to confirm expression

    • Size exclusion chromatography to assess oligomeric state

    • Thermal shift assays to evaluate stability

What is the most effective experimental design to study interaction partners of CXorf69?

Methodological Answer:
For uncharacterized proteins like CXorf69, identifying interaction partners is critical for understanding function. Design-of-Experiments (DOE) approaches can significantly enhance the efficiency of interaction studies .

  • Sequential Experimental Approach:

    • Begin with in silico prediction of potential interactors based on sequence homology

    • Perform pull-down assays with tagged CXorf69 protein

    • Validate interactions using orthogonal methods (reciprocal co-IP, FRET, PLA)

  • Statistical Design Considerations:

    • Implement multi-level experimental design to maximize information while minimizing experiments

    • Use paired statistical analysis to compare results between methods

    • Apply t-tests to determine statistical significance of interactions (p<0.05)

  • Integrated Data Analysis:

    • Combine computational predictions with experimental data to generate interaction networks

    • Apply correlation coefficients (e.g., r>0.7) to assess data reliability across methods

    • Consider both direct and indirect interactions in biological interpretation

The combination of computational and experimental approaches can significantly improve both efficiency and accuracy in identifying genuine interaction partners for uncharacterized proteins .

How should I validate the specificity of antibodies against CXorf69?

Methodological Answer:
For poorly characterized proteins like CXorf69, antibody validation is particularly challenging but critical for ensuring reliable experimental results.

  • Comprehensive Validation Protocol:

    • Express recombinant CXorf69 with epitope tags for positive controls

    • Generate knockout or knockdown cell models as negative controls

    • Test antibody in multiple applications (WB, IP, IHC, IF) to determine application-specific performance

  • Cross-Reactivity Assessment:

    • Perform peptide competition assays

    • Test antibody against related protein family members

    • Evaluate in tissues with known expression patterns based on RNA-seq data

  • Recommended Controls Table:

Validation MethodPositive ControlNegative ControlExpected Outcome
Western blotTagged recombinant proteinCXorf69 knockdown cellsSingle band at 83 kDa
ImmunoprecipitationLysate with overexpressed CXorf69Pre-immune serumEnrichment of CXorf69
ImmunofluorescenceCells with confirmed expressionPeptide competitionSpecific subcellular localization
Flow cytometryPermeabilized cells with confirmed expressionIsotype controlPopulation shift in positive cells

Remember to document all validation experiments thoroughly as they directly impact the reliability of downstream research findings.

Which research methodology is most appropriate for functional characterization of CXorf69?

Methodological Answer:
The selection of research methodology for uncharacterized proteins requires careful consideration of the nature of your research, norms in the field, and practical constraints .

  • Exploratory vs. Confirmatory Approaches:

    • Begin with exploratory research to generate hypotheses about CXorf69 function

    • Use qualitative approaches to develop potential theories about protein function

    • Follow with confirmatory research using quantitative methods to test specific hypotheses

  • Mixed-Methods Consideration:

    • A mixed-methods approach is optimal for uncharacterized proteins

    • Start with high-throughput screening (e.g., proteomics, transcriptomics)

    • Follow with targeted functional assays based on preliminary findings

    • Validate with genetic approaches (CRISPR knockout, knockdown, overexpression)

  • Practical Methodology Evaluation:

MethodologyAdvantageDisadvantageResource Requirements
Phenotypic ScreeningNo prior assumptions neededMay miss subtle phenotypesHigh-content screening equipment
Domain-based PredictionCost-effectiveRequires homology to known proteinsComputational resources
Interactome AnalysisProvides functional contextLabor intensiveMass spectrometry, antibodies
Genetic ManipulationDirect causality assessmentMay have compensatory mechanismsCRISPR reagents, cell models

When designing your research plan, consider the constraints of your laboratory setting and available resources, as theoretical designs may need to be adapted to practical conditions .

How can I resolve contradictory data when studying CXorf69?

Methodological Answer:
When working with uncharacterized proteins like CXorf69, contradictory data is common and requires systematic resolution approaches.

  • Statistical Analysis Framework:

    • Apply paired t-tests to determine if differences between methods are statistically significant

    • Calculate correlation coefficients between different experimental approaches

    • Use DOE models to identify potential variables causing contradictions

  • Resolution Strategy:

    • Systematically vary experimental conditions (cell type, tags, buffer conditions)

    • Implement DOE approaches to efficiently test multiple variables

    • Combine CFD (computational fluid dynamics) analysis with experimental data to gain comprehensive understanding of discrepancies

  • Data Integration Process:

    • Apply optimal multi-level design to identify critical variables

    • Generate response surfaces to visualize parameter interactions

    • Calculate shape factor and momentum thickness to quantify reliability

Remember that no statistical difference between CFD/experimental combined data sets and complete experimental data sets suggests your integrated approach is valid .

What are the most effective approaches to determine subcellular localization of CXorf69?

Methodological Answer:
Determining subcellular localization is a critical step in understanding protein function, particularly for uncharacterized proteins like CXorf69.

  • Comprehensive Localization Strategy:

    • Begin with in silico prediction of targeting sequences and transmembrane domains

    • Generate N- and C-terminal fluorescent protein fusions to visualize localization

    • Perform subcellular fractionation followed by western blotting

    • Validate with immunofluorescence using validated antibodies

  • Technical Considerations:

    • Evaluate potential artifacts from overexpression systems

    • Consider dynamic localization under different cellular conditions

    • Test in multiple cell types to identify cell-specific localization patterns

  • Advanced Approaches for Ambiguous Results:

    • Proximity labeling methods (BioID, APEX)

    • Super-resolution microscopy for precise spatial organization

    • Live-cell imaging to track dynamics and trafficking

Pay particular attention to potential differences between endogenous and recombinant protein localization patterns, as the His-tag used in recombinant expression could potentially interfere with localization signals.

How can I design experiments to determine if CXorf69 is involved in protein-protein interactions?

Methodological Answer:
For an uncharacterized protein like CXorf69, determining interaction networks is crucial for functional insights.

  • Systematic Screening Approach:

    • Implement affinity purification-mass spectrometry (AP-MS) with tagged CXorf69

    • Perform yeast two-hybrid screening against human cDNA libraries

    • Validate key interactions with bimolecular fluorescence complementation (BiFC)

    • Map interaction domains using deletion mutants

  • Control Strategy Table:

MethodPositive ControlNegative ControlData Quality Metrics
AP-MSKnown stable protein complexTag-only pulldownEnrichment ratio >5, FDR <0.05
Y2HKnown interacting pairEmpty vector constructsGrowth on selection media, X-gal activity
Co-IPTagged protein pairSingle expression controlCo-precipitation efficiency
FRETFusion protein positive controlNon-interacting protein pairFRET efficiency >10%
  • Data Analysis Framework:

    • Apply confidence scoring based on detection across multiple methods

    • Use interaction databases to build networks around novel interactions

    • Perform GO enrichment analysis to identify functional clusters

Given the limited knowledge about CXorf69, emphasize stringent controls and replicate experiments to minimize false positives.

What experimental approaches can determine the potential role of CXorf69 in cellular pathways?

Methodological Answer:
Since CXorf69 is a putative uncharacterized protein , determining its role in cellular pathways requires a multi-faceted approach.

  • Pathway Analysis Strategy:

    • Perform RNA-seq and proteomics after CXorf69 knockdown/overexpression

    • Conduct phospho-proteomics to identify signaling changes

    • Use pathway enrichment analysis to identify affected processes

    • Validate key findings with targeted functional assays

  • Experimental Design Framework:

    • Implement DOE approaches for efficient experimentation

    • Use paired experimental designs to reduce variability

    • Include time-course analyses to capture dynamic changes

  • Functional Validation Methods:

    • Reporter gene assays for specific pathway activation

    • Phenotypic assays based on pathway predictions

    • Epistasis analysis with known pathway components

    • Rescue experiments with wild-type and mutant constructs

When interpreting results, consider that CXorf69 may function in multiple pathways or have context-dependent roles depending on cell type or physiological conditions.

How should I approach the functional annotation of domains within CXorf69?

Methodological Answer:
Domain annotation for uncharacterized proteins like CXorf69 requires integration of computational prediction and experimental validation.

  • Sequential Approach:

    • Begin with computational domain prediction (SMART, Pfam, InterPro)

    • Generate a series of deletion constructs removing predicted domains

    • Express and purify domain-specific constructs for structural analysis

    • Perform functional assays comparing full-length and domain deletion variants

  • Domain Characterization Matrix:

Domain Analysis MethodInformation ProvidedTechnical LimitationsBest Applications
Sequence-based predictionEvolutionary relationshipsRequires homology to known domainsInitial characterization
Secondary structure predictionFolding patternsLow resolutionQuick assessment
Limited proteolysisDomain boundariesRequires optimizationExperimental boundary determination
Domain-specific antibodiesDomain accessibilityRequires validated antibodiesIn situ studies
  • Integrative Domain Mapping:

    • Correlate domain deletions with functional outcomes

    • Use hydrogen-deuterium exchange mass spectrometry to identify structured regions

    • Perform cross-linking studies to determine domain interactions

Remember that the full-length CXorf69 protein (1-83 amino acids) is relatively small, so it may contain only one or a few functional domains.

What are the most promising approaches to elucidate the physiological relevance of CXorf69?

Methodological Answer:
Determining physiological relevance of uncharacterized proteins requires integrating in vitro findings with in vivo models.

  • Translational Research Strategy:

    • Generate knockout mouse models using CRISPR/Cas9

    • Perform comprehensive phenotyping across tissues and developmental stages

    • Analyze tissue-specific expression patterns and correlation with pathological conditions

    • Conduct conditional knockout studies to address potential developmental lethality

  • Human-relevant Approaches:

    • Analyze patient-derived samples for expression changes in disease states

    • Identify potential mutations in patient populations through genomic database mining

    • Develop iPSC models from patients with relevant conditions

    • Use tissue-specific organoids to model function in complex systems

  • Integrated Analysis Framework:

    • Combine transcriptomic, proteomic, and metabolomic data to build comprehensive models

    • Apply systems biology approaches to position CXorf69 in biological networks

    • Develop predictive models that can be tested with targeted experiments

For truly impactful research, consider forming collaborations with clinical researchers to accelerate translation of basic findings to human health applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.